276
Views
1
CrossRef citations to date
0
Altmetric
Original Articles: BiGART 2023 Issue

Clinical implications of dose to functional lung volumes in the trimodality treatment of esophageal cancer

ORCID Icon, , , , , & show all
Pages 1488-1495 | Received 10 May 2023, Accepted 17 Aug 2023, Published online: 29 Aug 2023

References

  • van Hagen P, Hulshof MCCM, van Lanschot JJB, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366(22):2074–2084. doi: 10.1056/NEJMoa1112088.
  • Eyck BM, van Lanschot JJB, Hulshof MCCM, et al. Ten-year outcome of neoadjuvant chemoradiotherapy plus surgery for esophageal cancer: the randomized controlled CROSS trial. J Clin Oncol. 2021;39(18):1995–2004. doi: 10.1200/JCO.20.03614.
  • Bosch DJ, Muijs CT, Mul VEM, et al. Impact of neoadjuvant chemoradiotherapy on postoperative course after curative-intent transthoracic esophagectomy in esophageal cancer patients. Ann Surg Oncol. 2014;21(2):605–611. doi: 10.1245/s10434-013-3316-8.
  • Reynolds J V, Ravi N, Hollywood D, et al. Neoadjuvant chemoradiation may increase the risk of respiratory complications and sepsis after transthoracic esophagectomy. J Thorac Cardiovasc Surg. 2006;132(3):549–555. doi: 10.1016/j.jtcvs.2006.05.015.
  • Thomas M, Defraene G, Lambrecht M, et al. NTCP model for postoperative complications and one-year mortality after trimodality treatment in oesophageal cancer. Radiother Oncol. 2019;141:33–40. doi: 10.1016/j.radonc.2019.09.015.
  • Visser S, Ribeiro CO, Dieters M, et al. Robustness assessment of clinical adaptive proton and photon radiotherapy for oesophageal cancer in the model-based approach. Radiother Oncol. 2022;177:197–204.
  • Reynolds JV, Preston SR, O’Neill B, et al. Neo-AEGIS (neoadjuvant trial in adenocarcinoma of the esophagus and esophago-gastric junction international study): preliminary results of phase III RCT of CROSS versus perioperative chemotherapy (modified MAGIC or FLOT protocol). (NCT01726452). J Clin Oncol. 2021;39(suppl 15; abstr 4004). doi: 10.1200/JCO.2021.39.15_suppl.4004.
  • Galvin I, Drummond GB, Nirmalan M. Distribution of blood flow and ventilation in the lung: gravity is not the only factor. Br J Anaesth. 2007;98(4):420–428. doi: 10.1093/bja/aem036.
  • Farr KP, Kallehauge JF, Møller DS, et al. Inclusion of functional information from perfusion SPECT improves predictive value of dose-volume parameters in lung toxicity outcome after radiotherapy for non-small cell lung cancer: a prospective study. Radiother Oncol. 2015;117(1):9–16. doi: 10.1016/j.radonc.2015.08.005.
  • Hoffmann L, Mortensen H, Shamshad M, et al. Treatment planning comparison in the PROTECT-trial randomising proton versus photon beam therapy in oesophageal cancer: results from eight European centres. Radiother Oncol. 2022;172:32–41. doi: 10.1016/j.radonc.2022.04.029.
  • Chang DS, Lasley FD, Das IJ, et al. Normal tissue radiation responses. In: Chang DS, Lasley FD, Das IJ, et al., editors. Basic radiotherapy physics and biology. Cham: Springer International Publishing; 2014. p. 265–275.
  • Ding K, Cao K, Fuld MK, et al. Comparison of image registration based measures of regional lung ventilation from dynamic spiral CT with Xe-CT. Med Phys. 2012;39(8):5084–5098. doi: 10.1118/1.4736808.
  • Nyeng TB, Møller DS, Farr K, et al. A comparison of two methods for segmentation of functional volumes in radiotherapy planning of lung cancer patients. Acta Oncol. 2021;60(3):353–360. doi: 10.1080/0284186X.2021.1877811.
  • Vinogradskiy Y, Castillo R, Castillo E, et al. Results of a multi-institutional phase 2 clinical trial for 4DCT-ventilation functional avoidance thoracic radiation therapy. Int J Radiat Oncol Biol Phys. 2022;112(4):986–995. doi: 10.1016/j.ijrobp.2021.10.147.
  • Zhou PX, Wang RH, Yu H, et al. Different functional lung-sparing strategies and radiotherapy techniques for patients with esophageal cancer. Front Oncol. 2022;12:898141. doi: 10.3389/fonc.2022.898141.
  • Zhou P, Wang R, Yu H, et al. 4DCT ventilation function image-based functional lung protection for esophageal cancer radiotherapy. Strahlenther Onkol. 2023;199(5):445–455. doi: 10.1007/s00066-022-02012-2.
  • Morgan E, Soerjomataram I, Rumgay H, et al. The global landscape of esophageal squamous cell carcinoma and esophageal adenocarcinoma incidence and mortality in 2020 and projections to 2040: new estimates From GLOBOCAN 2020. Gastroenterology. 2022;163(3):649–658.e2. doi: 10.1053/j.gastro.2022.05.054.
  • Goense L, Meziani J, Bülbül M, et al. Pulmonary diffusion capacity predicts major complications after esophagectomy for patients with esophageal cancer. Dis Esophagus. 2019;32:1–7.
  • Miller R, Castillo R, Castillo E, et al. Characterizing pulmonary function test changes for patients with lung cancer treated on a 2-Institution, 4-dimensional computed tomography-ventilation functional avoidance prospective clinical trial. Adv Radiat Oncol. 2023;8(2):101133. doi: 10.1016/j.adro.2022.101133.
  • Brennan D, Schubert L, Diot Q, et al. Clinical validation of 4DCT-ventilation with pulmonary function test data. Int J Radiat Oncol Biol Phys. 2015;92(2):423–429. doi: 10.1016/j.ijrobp.2015.01.019.
  • Thomas M, Mortensen HR, Hoffmann L, et al. Proposal for the delineation of neoadjuvant target volumes in oesophageal cancer. Radiother Oncol. 2021;156:102–112. doi: 10.1016/j.radonc.2020.11.032.
  • McMillian N, Lenora Pluchino MA, Ajani JA, et al. NCCN guidelines version 2.2023 esophageal and esophagogastric junction cancers continue NCCN. J Natl Compr Canc Netw. 2023;21(4):393–422. doi: 10.6004/jnccn.2023.0019.
  • Slankamenac K, Graf R, Barkun J, et al. The comprehensive complication index: a novel continuous scale to measure surgical morbidity. Ann Surg. 2013;258(1):1–7. doi: 10.1097/SLA.0b013e318296c732.
  • Low DE, Alderson D, Cecconello I, et al. International consensus on standardization of data collection for complications associated with esophagectomy: esophagectomy complications consensus group (ECCG). Ann Surg. 2015;262(2):286–294. doi: 10.1097/SLA.0000000000001098.
  • Bender R, Lange S. Adjusting for multiple testing—when and how? J Clin Epidemiol. 2001;54(4):343–349. doi: 10.1016/s0895-4356(00)00314-0.
  • IBM Corp. IBM SPSS Statistics for Windows, Version 28.0. 2021.
  • Clavien PA, Barkun J, De Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250(2):187–196. doi: 10.1097/SLA.0b013e3181b13ca2.
  • Wilke TJ, Bhirud AR, Lin C. A review of the impact of preoperative chemoradiotherapy on outcome and postoperative complications in esophageal cancer patients. Am J Clin Oncol. 2015;38(4):415–421. doi: 10.1097/COC.0000000000000021.
  • Lee HK, Vaporciyan AA, Cox JD, et al. Postoperative pulmonary complications after preoperative chemoradiation for esophageal carcinoma: correlation with pulmonary dose-volume histogram parameters. Int J Radiat Oncol Biol Phys. 2003;57(5):1317–1322. doi: 10.1016/s0360-3016(03)01373-7.
  • Briere TM, Krafft S, Liao Z, et al. Lung size and the risk of radiation pneumonitis. Int J Radiat Oncol Biol Phys. 2016;94(2):377–384. doi: 10.1016/j.ijrobp.2015.10.002.
  • Tatsuno S, Doi H, Okada W, et al. Risk factors for radiation pneumonitis after rotating gantry intensity-modulated radiation therapy for lung cancer. Sci Rep. 2022;12(1):590. doi: 10.1038/s41598-021-04601-0.
  • Niezink AGH, de Jong RA, Muijs CT, et al. Pulmonary function changes after radiotherapy for lung or esophageal cancer: a systematic review focusing on dose-volume parameters. Oncologist. 2017;22(10):1257–1264. doi: 10.1634/theoncologist.2016-0324.
  • Belzer RB, Lewis RJ. The practical significance of measurement error in pulmonary function testing conducted in research settings. Risk Anal. 2019;39(10):2316–2328. doi: 10.1111/risa.13315.
  • Chen X, Du M, Tang H, et al. Comparison of pulmonary function changes between patients receiving neoadjuvant chemotherapy and chemoradiotherapy prior to minimally invasive esophagectomy: a randomized and controlled trial. Langenbecks Arch Surg. 2022;407(7):2673–2680. doi: 10.1007/s00423-022-02646-x.
  • Niezink AGH, Jong R D, Muijs CT, et al. Pulmonary function changes after radiotherapy for lung or esophageal cancer: a systematic review focusing on dose‐volume parameters. Oncologist. 2017;22(10):1257–1264. doi: 10.1634/theoncologist.2016-0324.
  • Agostoni P, Bussotti M, Cattadori G, et al. Gas diffusion and alveolar-capillary unit in chronic heart failure. Eur Heart J. 2006;27(21):2538–2543. doi: 10.1093/eurheartj/ehl302.
  • Bucknell NW, Hardcastle N, Bressel M, et al. Functional lung imaging in radiation therapy for lung cancer: a systematic review and meta-analysis. Radiother Oncol. 2018;129(2):196–208. doi: 10.1016/j.radonc.2018.07.014.
  • Du K, Bayouth JE, Cao K, et al. Reproducibility of registration-based measures of lung tissue expansion. Med Phys. 2012;39(3):1595–1608. doi: 10.1118/1.3685589.
  • Giuranno L, Ient J, De Ruysscher D, et al. Radiation-induced lung injury (RILI). Front Oncol. 2019;9:877. doi: 10.3389/fonc.2019.00877.
  • Nakajima Y, Kadoya N, Kimura T, et al. Variations between dose-ventilation and dose-perfusion metrics in radiation therapy planning for lung cancer. Adv Radiat Oncol. 2020;5(3):459–465. doi: 10.1016/j.adro.2020.03.002.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.